Co-Diagnostics, Inc.
  • ABOUT
    • Locations
      • Salt Lake City, Utah
      • Gujarat, India
    • CoSara Diagnostics Private Limited
    • Videos & Multimedia
    • Management
  • PRODUCTS
    • Diagnostic Solutions
      • Logix Smart™ MTB
      • Logix Smart™ Zika
      • Logix Smart™ ZDC
      • Logix Smart™ COVID-19
      • Logix Smart™ SARS-CoV-2 (RdRp/E)
      • Logix Smart™ ABC
    • Research Solutions
      • Logix Smart 2019-nCoV
    • Vector Control Solutions
    • Agricultural Solutions
    • Equipment
    • CoPrimers™/CODX™ Design Services
    • Email Alerts
  • APPLICATIONS
    • Screenings & Detection
    • Multiplexing
    • SNP Detection
    • Next-Gen Sequencing
    • Liquid Biopsy
  • TECHNOLOGY
    • What is PCR?
    • History
    • CoPrimers™
    • RapidProbes™
    • Hot Start
    • CoDx Design™ Process
  • Newsroom
    • Press Releases
    • In The News
    • Media Resources
      • RSS
  • INVESTORS
    • Events-Webcasts
    • Stock Information
      • Interactive Chart
      • Investment Calculator
      • Historical Stock Price
    • SEC filings
    • Financial Information
      • Key Ratios
    • Corporate Governance
      • Board Committees
    • Investor Resources
  • Resources
    • Terms And Conditions For Sales
    • Instructions For Use
    • Safety Data Sheets
    • Instructional Videos
    • Troubleshooting
    • Publications
  • CONTACT
Select Page

Co-Diagnostics, Inc. Announces Expansion of COVID-19 Test Orders in the United States

by Co-Diagnostics | Apr 20, 2020 | Market Update

Salt Lake City, Utah – April 20, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that Company COVID-19 test sales in the United States have continued...

Co-Diagnostics, Inc. COVID-19 Test Technology Validated for Use on Saliva Samples

by Co-Diagnostics | Apr 16, 2020 | News Release

Salt Lake City, Utah – April 16, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that OralDNA® Labs, a CLIA-certified laboratory, has...

Co-Diagnostics, Inc Contracts with Promega Corp for COVID-19 Test Manufacturing as Company Expands Domestic Customer Base

by Co-Diagnostics | Apr 14, 2020 | News Release

Salt Lake City, Utah – April 14, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it has contracted with Madison, Wisconsin-based...

Co-Diagnostics, Inc Receives FDA Emergency Use Authorization for COVID-19 Test

by Co-Diagnostics | Apr 6, 2020 | News Release

Salt Lake City, Utah – April 6, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ Coronavirus COVID-19 Test has obtained Emergency...

Follow us on Facebook

https://www.facebook.com/codiagnostics/
design by TYMcreative